A detailed history of Essex Financial Services, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Essex Financial Services, Inc. holds 7,020 shares of NVS stock, worth $732,045. This represents 0.04% of its overall portfolio holdings.

Number of Shares
7,020
Previous 8,401 16.44%
Holding current value
$732,045
Previous $894,000 9.73%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$106.13 - $120.89 $146,565 - $166,949
-1,381 Reduced 16.44%
7,020 $807,000
Q2 2024

Jul 31, 2024

BUY
$92.57 - $107.37 $199,395 - $231,274
2,154 Added 34.48%
8,401 $894,000
Q1 2024

Apr 23, 2024

SELL
$95.27 - $108.47 $15,147 - $17,246
-159 Reduced 2.48%
6,247 $604,000
Q4 2023

Feb 05, 2024

SELL
$92.27 - $101.54 $16,147 - $17,769
-175 Reduced 2.66%
6,406 $646,000
Q3 2023

Nov 15, 2023

SELL
$94.73 - $105.13 $16,577 - $18,397
-175 Reduced 2.59%
6,581 $670,000
Q2 2023

Aug 08, 2023

SELL
$92.52 - $104.91 $68,557 - $77,738
-741 Reduced 9.88%
6,756 $681,000
Q1 2023

May 11, 2023

BUY
$80.03 - $92.81 $7,362 - $8,538
92 Added 1.24%
7,497 $689,000
Q4 2022

Feb 10, 2023

BUY
$75.55 - $92.52 $75 - $92
1 Added 0.01%
7,405 $671,000
Q3 2022

Nov 07, 2022

SELL
$74.61 - $87.26 $30,963 - $36,212
-415 Reduced 5.31%
7,404 $563,000
Q2 2022

Aug 01, 2022

SELL
$80.52 - $93.75 $21,981 - $25,593
-273 Reduced 3.37%
7,819 $661,000
Q1 2022

Apr 21, 2022

SELL
$80.11 - $90.62 $16,983 - $19,211
-212 Reduced 2.55%
8,092 $710,000
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $38,335 - $42,390
481 Added 6.15%
8,304 $726,000
Q3 2021

Nov 10, 2021

BUY
$81.78 - $95.14 $88,240 - $102,656
1,079 Added 16.0%
7,823 $640,000
Q1 2021

May 11, 2021

SELL
$83.5 - $98.47 $71,309 - $84,093
-854 Reduced 11.24%
6,744 $576,000
Q4 2020

Feb 05, 2021

BUY
$78.07 - $94.43 $151,611 - $183,383
1,942 Added 34.34%
7,598 $717,000
Q3 2020

Nov 10, 2020

BUY
$82.14 - $91.0 $74,993 - $83,083
913 Added 19.25%
5,656 $492,000
Q2 2020

Aug 06, 2020

SELL
$80.93 - $91.1 $35,042 - $39,446
-433 Reduced 8.37%
4,743 $414,000
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $217,734 - $305,049
-3,081 Reduced 37.31%
5,176 $427,000
Q4 2019

Jan 30, 2020

SELL
$84.35 - $95.37 $6,579 - $7,438
-78 Reduced 0.94%
8,257 $782,000
Q3 2019

Nov 04, 2019

BUY
$85.54 - $94.26 $2,822 - $3,110
33 Added 0.4%
8,335 $724,000
Q2 2019

Jul 30, 2019

SELL
$75.4 - $92.8 $22,016 - $27,097
-292 Reduced 3.4%
8,302 $758,000
Q1 2019

May 02, 2019

SELL
$75.32 - $86.15 $1,129 - $1,292
-15 Reduced 0.17%
8,594 $826,000
Q4 2018

Feb 07, 2019

SELL
$73.66 - $82.02 $4,345 - $4,839
-59 Reduced 0.68%
8,609 $739,000
Q3 2018

Nov 05, 2018

BUY
$66.94 - $77.43 $19,613 - $22,686
293 Added 3.5%
8,668 $747,000
Q2 2018

Aug 07, 2018

SELL
$64.91 - $73.36 $32,455 - $36,680
-500 Reduced 5.63%
8,375 $633,000
Q1 2018

May 03, 2018

BUY
$70.39 - $84.15 $13,866 - $16,577
197 Added 2.27%
8,875 $718,000
Q4 2017

Feb 07, 2018

SELL
$72.33 - $77.64 $41,300 - $44,332
-571 Reduced 6.17%
8,678 $729,000
Q3 2017

Nov 03, 2017

BUY
$74.14 - $77.27 $2,224 - $2,318
30 Added 0.33%
9,249 $794,000
Q2 2017

Aug 07, 2017

BUY
N/A
9,219
9,219 $770,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Essex Financial Services, Inc. Portfolio

Follow Essex Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Financial Services, Inc. with notifications on news.